1 The eects of wortmannin, an inhibitor of phosphatidylinositol (PI) kinases and myosin light chain kinase, on the quantal release of neurotransmitter from mouse phrenic nerve were investigated. 2 Wortmannin (10 ± 100 mM) initially enhanced, thereafter progressively depressed spontaneous quantal discharge (miniature endplate potential, mepp). The mean amplitude and the amplitude distribution of mepp were not altered. 3 The compound inhibited and prevented the intensive quantal release evoked by high KC1 solution as well as the mepp burst induced by a-latrotoxin, a polypeptide toxin that possesses Ca 2+ -independent synaptic action to trigger quantal release. The inhibitory actions of wortmannin were partially reversible. 4 Wortmannin depressed the amplitude of endplate potentials (epps) and increased the coecient of variance of epps. The pro®le of epps in response to high frequency nerve stimulation exhibited uctuations between run-down and run-up. The phenomenon is thus dierent from the consistency of run-up characteristic as the motor nerve Ca 2+ channel is blocked by o-agatoxin IVA. 5 LY294002, another inhibitor of PI 3-kinase, raised mepp frequency without causing late phase suppressions. The compound did not inhibit KC1-, a-latrotoxin-or nerve stimulation-evoked quantal release. 6 The results suggest that wortmannin could depress quantal release beyond the step of Ca 2+ channel blockade, probably by interfering with the exocytotic cascade.
Introduction
Under physiological conditions, the orthograde communication from nerve to skeletal muscle relies on sophisticated synaptic transmission. On the presynaptic side, the motor nerve terminal is endowed with secretory organelles and ecient machineries for packaging and release of the neurotransmitter ± acetylcholine. The apposed postsynaptic muscle membrane is furnished with high density of nicotinic acetylcholine receptors for the generation of endplate potentials (epps). According to the hypothesis of quantal release, neurotransmission is achieved by the fusion of synaptic vesicles and nerve membrane with subsequent discharge of vesicular content ± an exocytotic process involving complicated protein interactions and phospholipid rearrangement (Robinson & Martin, 1998; FernaÂ ndez-ChacoÂ n & Su È dhof, 1999) . The exocytosis can be facilitated by an appropriate elevation of intraterminal Ca 2+ concentration or by a-latrotoxin, a protein component of black widow spider venom (Fesce et al., 1986; Rosenthal & Meldolesi, 1989) . To maintain homeostasis and to replenish synaptic vesicles, the vesicular membrane intercalated with nerve membrane is retrieved by endocytosis (Heuser & Reese, 1973; Artalejo et al., 1995) . Recent studies have revealed that speci®c proteins and phospholipids play important roles in the transport of membrane components and exocytotic release of bioactive molecules (De Camilli et al., 1996; Corvera & Czech, 1998) . For example, myosin light chain kinase might mediate the exocytosis of catecholamine in chroman cell (Kumakura et al., 1994) and gonadotropin in pituitary cell (Rao et al., 1997) , and phosphatidylinositol (PI) kinase might be implicated in insulin release (Straub & Sharp, 1996) and mast cell degranulation (Marquardt et al., 1996) . We had characterized that wortmannin, an inhibitor of myosin light chain kinase and PI kinases (Nakanishi et al., 1992; Powis et al., 1994) , interferes with the excitation-contraction coupling of skeletal muscle and depresses the contractile response (Hong & Chang, 1998) . Here, we explore the presynaptic action of wortmannin in the mouse neuromuscular junction. The agent inhibits exocytosis evoked by nerve stimulation as well as Ca 2+ -independent quantal release provoked by a-latrotoxin.
Methods

Motor nerve-skeletal muscle preparation
Phrenic nerve-hemidiaphragms were isolated from mice (ICR strain, 20 ± 25 g) killed by a heavy blow and exsanguination. Preparation was bathed in Tyrode solution (composition in mM: NaC1 137, KC1 2.8, CaC1 2 1.8, MgC1 2 1.1, NaHCO 3 , 11.9, NaH 2 PO 4 0.33 and dextrose 11.2) maintained at 35 ± 378C with the pH adjusted at 7.3 ± 7.4 by aeration with 5% CO 2 in O 2 . Phrenic nerve was stimulated with supramaximal rectangular pulses of 0.03 ms duration. When appropriate, the organ bath solution was renewed with Tyrode solution every 15 min to washout wortmannin, a-latrotoxin or high KC1.
Electrophysiological recording
Glass microelectrodes for intracellular recording of miniature endplate potentials (mepps) and epps were ®lled with 3 M KCl (resistance 5 ± 10 MO). To record epps, preparations were immobilized with m-conotoxin (Hong & Chang, 1995) . Compound nerve action potentials were recorded extracellularly with a glass microelectrode (®lled with 1 M NaCl, resistance 20 ± 40 MO) pierced through the encapsulating sheath of the trunk of phrenic nerve. Membrane potentials and epps were d.c.-coupled whereas high gain signals of mepps and compound nerve action potentials were recorded in a.c. mode. Waveforms were digitized and displayed on a thermal recorder (Gould TA5000). The frequency response of the recording system was 10 kHz. Rise times (time-to-peak) and durations (the time spanning 20% peak amplitude) of mepps and epps were calculated. Epp amplitudes were corrected for non-linear summation, assuming 0 mV for the reversal potential, and then normalized to a resting membrane potential of 780 mV (c.f. Chang et al., 1986) . 
Statistics
Mepp burst was de®ned as a gust of mepp-like discharges exceeding the basal level by either 430 events/s and persisting for at least 3 s, or 4100 events/s lasting for longer than 0.3 s, followed by remission of the intensive ®ring. Large mepps (44 mV or 42.5-fold average amplitude) with long rise-times (42 ms) were included in the counting of discharge events but not in the estimation of mean amplitude. For each preparation, experiments were segmented into several parts (control, pretreatment, test or washout). For every portion, 4 ± 7 dierent endplates were monitored. Each intracellular impalement was maintained for 5 min to sample mepps. Epp amplitude was the mean of 20 epps evoked at 0.3 Hz during the last minute of recording. The pro®le of epps in response to high frequency nerve stimulation (50 ± 100 Hz for 2 ± 4 s) was arbitrarily classi®ed into three categories according to the ratio of steady state epps (the mean amplitude of the 16th to the 100th epps) relative to the ®rst epp: run-down (when the value was 580%), run-up (when the value was 4150%), or¯at (between 80 ± 150%). Data, expressed in means+s.e., were pooled from 3 ± 6 preparations. Dierences between means were considered signi®cant by Student's t-test with a P value less than 0.05.
Results
Biphasic eects of wortmannin on mepps
Firstly, the eects of wortmannin on spontaneous quantal discharge were investigated. In the in vitro condition, phrenic nerve discharged quantal events at 0.5 ± 2 events/s for the initial 2 h and gradually to 2 ± 3 events/s at 3 ± 4 h (Figure 1) . Addition of wortmannin (10 ± 100 mM) elevated the mepp frequency up to 10 events/s (Figure 1 ) but mepp burst was never detected. The facilitation phase lasted for 1 ± 2 h, thereafter mepp frequency decreased to 0.05 ± 2 events/s at 3 ± 4 h. The value is signi®cantly less than the corresponding control. The onset and magnitude of facilitation and inhibition were related to the concentration of wortmannin. The suppression of mepp frequency was partially reversible, e.g. mepp frequency was 50.05 events/s 4 h after treatment with wortmannin 100 mM, however, after washout of wortmannin the frequency increased to 1 ± 2 events/s. During the facilitation phase, the amplitude distribution of mepps was unchanged ( Figure 1B ). Even after long-term (3 ± 6 h) treatment, wortmannin did not cause changes in mepp amplitude (1.5+0.3 vs 1.7+0.2 mV, n=4, 21 ± 25 endplates) nor in mepp duration (3.9+0.4 vs 3.4+0.3 ms). In Ca 2+ -free Tyrode solution (CaC1 2 substituted by equi-moles of MgC1 2 or CoCl 2 ), wortmannin also produced biphasic changes in mepp frequency, though the facilitatory eect was less marked than that in normal Tyrode solution (not shown).
Depression of KCl-evoked quantal discharge
In the second set of experiments, the eects of wortmannin on Ca
2+
-dependent quantal release were studied. To compromise high KC1 solution-induced reduction of the electrochemical gradient for nicotinic receptor-cation channel, KC1 concentration was raised to 17 mM. Within 1 min of solution change to high KC1 medium, the muscle membrane depolarized by *20 mV (763.5+2.9 vs 782.3+2.1 mV, n=5, 26 endplates). At the same time mepp amplitude decreased moderately (1.0+0.2 Figure 2A and B) but mepp frequency increased substantially to 35 ± 60 events/s. The increase of mepp frequency persisted at least 5 h. Application of wortmannin (30 ± 100 mM) progressively depressed the high level quantal discharge to 53 events/s in 2 h (Figure 2A and B). When the preparation was pretreated with wortmannin, subsequent incubation with high KC1 solution elicited a limited increase of quantal discharge (55 events/s, Figure 2C ). By contrast, after washout of wortmannin, high KCl solution elicited a signi®cant increase of mepp frequency to 10 ± 20 events/s ( Figure 2B and C).
Inhibition of a-latrotoxin-induced mepp burst
It has long been known that a-latrotoxin can evoke exocytosis independent of extracellular ion in¯uxes and Ca 2+ release from intraterminal stores (Rosenthal et al., 1990; Lang et al., 1998) . We examined the eects of wortmannin on this mode of neurotransmitter release. Shortly after (*10 ± 20 min) bath application of a-latrotoxin (1 ± 3 nM), nerve terminals intermittently generated mepp bursts, which often exceeded 500 ®rings/s and lasted 2 ± 10 s ( Figure 3A ). For each endplate examined, 2 ± 7 bursts were sampled within the 5 min observation period. The membrane around the endplate area depolarized by *5 mV during bursts (775.9+2.2 vs 781.6+1.9 mV, n=5, 28 endplates), while restored to control level during dormant period (779.4+2.1 mV). Burst episodes recurred for 5 h, though at 4 ± 5 h the burst intensity decreased (burst episode reduced to 2 ± 3 bursts/5 min, burst duration shortened to 2 ± 5 s, and discharges within burst decreased to 50 ± 200 events/s). Even after long-term treatment with a-latrotoxin, nerve stimulation (in the presence of m-conotoxin to block muscular Na + channels and twitches) still evoked epps, indicating that the releasable neurotransmitter pools
were not yet exhausted. The epp amplitude, however, was reduced by *40% (21.4+3.6 vs 34.7+2.8 mV, n=5, 25 endplates).
Wortmannin (10 ± 100 mM), in addition to depress non-burst quantal discharge, progressively reduced the toxin-induced mepp bursts. Within 40 ± 80 min, depending on the concentration of wortmannin employed, massive quantal release was reduced to 52 bursts/5 min accompanied by shortened burst duration (52 s/burst) and diminished quantal release within bursts (5100 events). After long-term treatment with wortmannin for 2 ± 3 h bursts were not detected, as illustrated in Figure 3A . The inhibition time course and inhibition potency of wortmannin on mepp bursts were similar to those on KC1-triggered quantal releases. When the preparation was ®rst treated with wortmannin to suppress quantal release, subsequent application of a-latrotoxin did not elicit burst discharges ( Figure 3B, top panel) . Washout of both wortmannin and a-latrotoxin partially restored mepp bursts. In Ca 2+ -free Tyrode solution, a-latrotoxin also evoked mepp bursts. This toxin-induced intensive release was inhibited if the preparation had been pretreated with wortmannin (not shown).
Eects of wortmannin on epps
The above results indicate that wortmannin depressed KC1-or a-latrotoxin-evoked intensive asynchronous quantal release. The eects of wortmannin on nerve stimulation-evoked phasic quantal release were also explored. Contrary to the marked initial stimulatory eect on the spontaneous quantal discharge, wortmannin produced a signi®cant inhibition of epps (evoked at 0.3 Hz) within 10 min of application (Figure 4) . The onset of inhibitory action on epps preceded that on spontaneous discharge by *30 min. The epp amplitude 4 h after treatment with wortmannin at 10, 30 and 100 mM was depressed by *50, 85 and 95%, respectively. Because the mepp amplitude was unchanged and there were no signi®cant alterations in epp rise times (0.9+0.2 vs 0.7+0.2 ms, n=5, 24 ± 29 endplates) and epp durations (3.8+0.4 vs 3.3+0.3 ms), it seems that the quantal content of epps, estimated by the direct method, decreased in parallel to the extent of epp inhibition. Intensive nerve stimulations (trains of pulses at 50 Hz for 2 s every 30 s) did not accelerate the rate of inhibition. The epp amplitude was restored partially after washout of wortmannin (Figure 4) . At high concentration (300 mM), wortmannin depressed the amplitude of compound nerve action potentials and caused abrupt failure of epps (rather than graded depression). In view of an inhibitory eect of wortmannin on muscle Na + channel (Hong & Chang, 1998) , these results suggest that at high concentration the agent could interrupt impulse conduction of the phrenic nerve.
Since the phrenic nerve discharges at high rates under physiological conditions, the eects of wortmannin on evoked quantal release was studied further by analyses of the pro®le of epps under high frequency (50 ± 100 Hz) nerve stimulation. In control, the epps from every endplate ran down consistently to a steady state, being 70 ± 80% that of the ®rst epp. After treatment with wortmannin (30 ± 100 mM) for 40 ± 240 min when epp amplitude was depressed down to 5 ± 10 mV (i.e., 15 ± 30% of control level), the pro®le of epps exhibited run-up (16 out of 37 endplates, for de®nitions see Methods),¯at (11/ 37) or run-down (10/37) ( Figure 5 ). The overall epp amplitude at steady state was 151+12% relative to the ®rst one. Statistical analyses revealed that during high frequency stimulation wortmannin increased the coecient of variance of epps (0.211+0.026 vs 0.041+0.011, pooled from 27 ± 37 endplates, n=5 ± 6). Depression of epp amplitude and increase of the coecient of variance of epps are indications of reduced quantal release, which probably results from decreased Ca 2+ in¯ux. At the neuromuscular junction, inhibition of Ca 2+ in¯ux tend to induce a run-up pro®le of synaptic transmissions during high frequency stimulation (Magleby, 1973) . We therefore compared the eects of wortmannin with those induced by o-agatoxin IVA, which inhibits depolarizationinduced, but not a-latrotoxin-induced, quantal release by selective blockade of P/Q type Ca 2+ channels on the motor nerve terminal (Hong & Chang, 1995) . o-Agatoxin IVA (5 ± 10 nM) depressed epp amplitudes to 5 ± 10 mV in 20 ± 40 min without increasing spontaneous quantal discharge. Although the degree of the inhibition of epp was similar to that produced by wortmannin, the epps on high frequency nerve stimulation always displayed run-up with respect to the ®rst one (up to 235+26%, n=4, 19 endplates, Figure 5E ), qualitatively and quantitatively dierent from those treated with wortmannin. These results suggest that the suppression of phasic quantal release by wortmannin was not due entirely to a blockade of Ca 2+ channel.
Eects of LY294002
Due to the tiny structure of the nerve terminal, it is rather dicult to assay the in¯uence of wortmannin on the activity of intraterminal kinase. The role of kinases in transmitter release was estimated pharmacologically by comparing the eects of wortmannin with those of LY294002, another membrane permeable inhibitor of PI 3-kinase . At concentration range of 10 ± 100 mM, LY294002 elevated mepp frequency to 5*10 events/s. The increase lasted for 5 h ( Figure  1A ). Spontaneous discharges with long rise time and large amplitude occurred frequently (not shown). When treated with high concentration of LY294002 (100 mM), junctional as well as extra-junctional membranes depolarized by *10 mV (770.2+2.5 vs 782.3+1.7 mV, n=4, 22 endplates). As muscle membrane depolarized, mepp amplitude decreased by *30% (1.2+0.2 vs 1.7+0.3 mV) and epp amplitude decreased by a similar extent (24.3+2.1 vs 35.7+1.8 mV, n=3, 17 endplates). After correction and normalization, the epp amplitude (32.5+1.9 mV) was only slightly less than that of control, suggesting that the release of neurotransmitter on nerve stimulation was not greatly depressed. These eects of LY294002 were partially reversible. On high frequency nerve stimulation, the epps at steady state were 79+3% relative to the ®rst epp (n=3, 17 endplates) and the epp pro®le was similar to that of control. Unlike wortmannin, LY294002 did not inhibit the quantal discharge evoked by high KC1 solution ( Figure 2C , c.f. Figure 2B for the control frequency increase in high KC1 medium) or by a-latrotoxin (not shown).
Discussion
At the neuromuscular junction wortmannin suppressed depolarization-induced quantal discharge and increased the coecient of variance of epps without alteration of the elementary quantal size. These results suggest that in the presence of wortmannin fewer quanta are recruited for triggered exocytosis. However, the pro®le of epps on high frequency stimulation was not invariably characterized by prominent facilitation, and was thus unlike the welldocumented run-up phenomenon whenever the quantal release is depressed by blockade of nerve terminal Ca 2+ channel. In addition to inhibiting Ca 2+ -dependent quantal release, wortmannin also suppressed the quantal discharge provoked by a-latrotoxin. a-Latrotoxin stimulates exocytosis either in Ca 2+ -containing or Ca
2+
-free medium (Misler & Hurlbut, 1979; Rosenthal & Meldolesi, 1989; Lang et al., 1998) .
Research data indicate that a-latrotoxin is translocated through/incorporated into presynaptic membrane. The toxin binds in a Ca 2+ -dependent manner to neurexin, a neuron surface protein, and might complex with nerve membrane to form a cation ionophore (Rosenthal et al., 1990; Filippov et al., 1994; Missler & SuÈ dhof, 1998; Sugita et al., 1999) . The in¯ux of Ca 2+ through this non-selective channel undoubtedly contributes to the increased exocytosis. In Ca 2+ -free medium, the toxin binds to a G-protein-coupled receptor, which interacts with syntaxin, one of the key synaptic proteins in membrane fusion (Krasnoperov et al., 1997) . Results from molecular and genetic approaches suggest that the receptor might function as a conduit for directing the toxin to the unknown downstream site of action without transducing exocytosis (Ichtchenko et al., 1998; Sugita et al., 1999) , or might serve as an inhibitory modulator for quantal secretion (Bittner et al., 1998) . Roles of the endogenous ligand of this Ca 2+ -independent receptor for a-latrotoxin await characterizations.
Mode of action of wortmannin
The inhibition of nerve stimulation-as well as a-latrotoxinevoked quantal release suggests that, at the neuromuscular junction, wortmannin could attack Ca 2+ -regulated and Ca 2+ -independent exocytosis pathways. Alternatively, reduced quantal discharge could be due indirectly to decreased transmitter depots. Histological examinations of presynaptic ultrastructure could unravel whether wortmannin depletes synaptic vesicles.
A well-known class of inhibitor targeting on exocytotic release is botulinum/tetanus toxin, which enzymatically excises speci®c vesicle membrane protein (synaptobrevin) and presynaptic membrane proteins (syntaxin and synaptosome associated protein of 25 kDa ± SNAP25, see Jahn et al., 1995 for review) . These proteins are essential to the fusion of vesicle with nerve membrane, and a dysfunction of any one of them retards exocytosis (Jahn et al., 1995; Robinson & Martin, 1998) . Polypeptide toxin carrying intrinsic phospholipase A 2 activity, such as b-bungarotoxin, is another class. These neurotoxins suppress quantal release probably by Ca 2+ -activated enzymatic destruction of the membrane architecture of the nerve terminal (Fletcher & Rosenberg, 1997) . The quasi-irreversible nature and nerve activity-dependent inhibition by these presynaptic neurotoxins contrast with the stimulus-independent eect of wortmannin, suggesting that, if wortmannin acts on these steps, the action mechanism is dierent from the polypeptide neurotoxins.
Given that phosphoinositides and PI kinases play important roles in vesicle exocytosis and membrane trac (Hay et al., 1995; De Camilli et al., 1996) and that wortmannin, by inhibition of PI kinases, retards exocytosis in neuroendocrine and lymphoid cells (Folli et al., 1997; Martin, 1997) , wortmannin might target similar critical steps to inhibit quantal release in the motor nerve. The partial reversibility in the mouse neuromuscular junction might be due to tissueand species-dierence (c.f. Burke et al., 1996) . However, since the concentrations of wortmannin used were greater than those claimed for speci®c inhibition of the enzymes, and LY294002 did not inhibit exocytosis, it remains to be elucidated whether the depression of quantal release in the nerve-muscle tissue is ascribed to the inhibition of PI kinases. In cerebral cortical synaptosome, although PI kinase actively regulates Ca 2+ -dependent exocytosis, wortmannin does not inhibit glutamate release (Wiedemann et al., 1998) .
Despite the inhibition of evoked release, wortmannin increased spontaneous quantal discharge ± at least before this action was dominated by depression phase. Elevated mepp frequency could be due to increased Ca 2+ in¯ux, which would be blunted by exclusion of extracellular Ca
2+
, and/or release of intracellular Ca 2+ , which would tend to facilitate evoked release also. However, the experimental data do not favour these possibilities. Impairment of evoked quantal release with simultaneous recruitment of spontaneous quantal discharge are characteristics of the synaptic transmission in synaptotagmin-de®cit mutant of Drosophila (Broadie 1995; Littleton & Bellen, 1995) . Synaptotagmin is a vesicle membrane associated protein, which could function as a fusion clamp to prevent spontaneous fusion and to control regulated exocytosis . As the Ca 2+ channel of nerve terminal is activated, the C 2 domain of synaptotagmin binds with Ca 2+ , which not only changes the speci®city of phosphoinositide binding to synaptotagmin but also disables the inhibitory function of synaptotagmin (Schiavo et al., 1996; Ubach et al., 1998) . These reactions together with the recruitments of cytosolic fusion/regulatory proteins enable the juxta-paired synaptobrevin-syntaxin-SNAP25 to catalyze Ca 2+ -dependent exocytosis. (FernaÂ ndez-ChacoÂ n & Su È dhof, 1999) . It is possible that wortmannin might alter the functions of synaptotagmin and other intraterminal proteins to dierently aect spontaneous exocytosis and Ca 2+ -triggered multiquantal release.
Because both wortmannin and LY294002 elevated mepp frequency, further experiments could verify whether PI kinases modulate spontaneous quantal discharge.
In conclusion, aside from possible depression of Ca 2+ in¯ux and interference of phosphoinositide metabolism, wortmannin impairs neurotransmitter release from motor nerve probably via modi®cation of exocytotic cascade. This work is supported by grants from National Science Council (NSC 89-2314-B002-).
